Found 25 matching trials
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was designed to investigate the 1 year efficacy and safety of th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD PHASE2 The overall objective of this study is to determine an optimal dose and dos...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The purpose of this study is to evaluate, after 1 week of dosing, the effic...
Show More Location
Clinical Research of West Florida, Inc.
Learn More & Join Trial
AMPLIFY - D6571C00001 Duaklir USA Phase III Study PHASE3 This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Show More Learn More & Join Trial
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1 PHASE4 A randomized, placebo-controlled, double-blind, parallel group, multi cente...
Show More Location
205.477.001039 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease PHASE3 The study is intended to characterize the lung function profile of BI1744 i...
Show More Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD PHASE4 This study purpose is to further study the profiles of glycopyrronium (NVA2...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2 PHASE4 A randomized, placebo-controlled, double-blind, parallel group, multi-cente...
Show More Location
205.478.00243 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Show More Location
Novartis Investigator Site
Learn More & Join Trial